Ventricular dyskinesia is a medical condition characterized by abnormal, uncoordinated movement of the walls of the heart's ventricles during contraction. This disorder disrupts the synchronized pumping action of the heart, leading to inefficient blood circulation. Often associated with underlying heart conditions or cardiac events, ventricular dyskinesia poses significant risks, including impaired cardiac function and an increased likelihood of complications such as heart failure or arrhythmias. Diagnosis typically involves advanced imaging techniques, such as echocardiography, to assess the motion of the heart walls. Treatment strategies may include addressing the underlying cause, managing symptoms, and, in severe cases, surgical interventions to restore normal heart function. Effective management requires a comprehensive approach, often involving collaboration between cardiologists and other healthcare professionals to optimize patient outcomes.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India